Literature DB >> 18090288

Prevalence of HIV-2 and HIV-1 group O infections among new HIV diagnoses in France: 2003-2006.

Francis Barin1, Françoise Cazein, Florence Lot, Josiane Pillonel, Sylvie Brunet, Damien Thierry, Florence Damond, Françoise Brun-Vézinet, Jean-Claude Desenclos, Caroline Semaille.   

Abstract

French national surveillance of new HIV diagnoses included the collection of dried serum spots to identify HIV serotypes. Between January 2003 and June 2006, 10,184 new diagnoses were reported. The proportions of HIV-2 and HIV-1 group O infections were 1.8 and 0.1%, respectively. Most of these cases occurred in patients infected through heterosexual contact and originated from the corresponding endemic areas. Three cases of HIV-2 infections were reported in non-African men having sex with men.

Entities:  

Mesh:

Year:  2007        PMID: 18090288     DOI: 10.1097/QAD.0b013e3282f15637

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Human immunodeficiency virus type 2 infections in Austria.

Authors:  Ninon Taylor; Jan Marco Kern; Wolfgang Prammer; Alois Lang; Bernhard Haas; Martin Gisinger; Robert Zangerle; Alexander Egle; Richard Greil; Hannes Oberkofler; Josef Eberle
Journal:  Wien Klin Wochenschr       Date:  2014-01-18       Impact factor: 1.704

2.  Improving HIV-2 detection by a combination of serological and nucleic acid amplification test assays.

Authors:  Anna Rita Ciccaglione; Michela Miceli; Giulio Pisani; Roberto Bruni; Paola Iudicone; Angela Costantino; Michele Equestre; Elena Tritarelli; Cinzia Marcantonio; Paola Tataseo; Maria Cristina Marazzi; Susanna Ceffa; Giovanna Paturzo; Anna Maria Doro Altan; Massimo Magnano San Lio; Sandro Mancinelli; Massimo Ciccozzi; Alessandra Lo Presti; Giovanni Rezza; Leonardo Palombi
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

3.  A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus.

Authors:  Shengwen Xiong; Pedro Borrego; Xiaohui Ding; Yuanmei Zhu; Andreia Martins; Huihui Chong; Nuno Taveira; Yuxian He
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

Review 4.  Update on human immunodeficiency virus (HIV)-2 infection.

Authors:  Omobolaji T Campbell-Yesufu; Rajesh T Gandhi
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

Review 5.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

6.  Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors.

Authors:  Yunfeng Tie; Yuan-Fang Wang; Peter I Boross; Ting-Yi Chiu; Arun K Ghosh; Jozsef Tozser; John M Louis; Robert W Harrison; Irene T Weber
Journal:  Protein Sci       Date:  2012-01-24       Impact factor: 6.725

7.  Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections.

Authors:  J-C Plantier; M Djemai; V Lemée; A Reggiani; M Leoz; L Burc; A Vessière; D Rousset; J-D Poveda; C Henquell; A Gautheret-Dejean; F Barin
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

8.  Biological signature characteristics of primary isolates from human immunodeficiency virus type 1 group O in ex vivo human tonsil histocultures.

Authors:  Silvia Geuenich; Lars Kaderali; Ina Allespach; Serkan Sertel; Oliver T Keppler
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

9.  Structural evidence for effectiveness of darunavir and two related antiviral inhibitors against HIV-2 protease.

Authors:  Andrey Y Kovalevsky; John M Louis; Annie Aniana; Arun K Ghosh; Irene T Weber
Journal:  J Mol Biol       Date:  2008-09-20       Impact factor: 5.469

10.  Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting.

Authors:  Juliette Pavie; Anne Rachline; Bénédicte Loze; Laurence Niedbalski; Constance Delaugerre; Eric Laforgerie; Jean-Christophe Plantier; Willy Rozenbaum; Sylvie Chevret; Jean-Michel Molina; François Simon
Journal:  PLoS One       Date:  2010-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.